• Subscribe
  • Magazine
  • Past Issues
  • Surveys
  • Industry Statistics
  • About Us
  • Members Only
  • Best Places to Work
    • Recent Quotes
    My Watchlist
    Indicators
    PennEnergy Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Nls Pharmaceutics Ltd (NQ: NLSP )

    0.1423 -0.0239 (-14.38%)
    Streaming Delayed Price Updated: 2:56 PM EDT, May 31, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 919,068
    Open 0.1620
    Bid (Size) 0.1416 (77)
    Ask (Size) 0.1447 (3)
    Prev. Close 0.1662
    Today's Range 0.1410 - 0.1620
    52wk Range 0.1130 - 1.530
    Shares Outstanding N/A
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    NLS Pharmaceutics Reports Positive Results from Study KO-874 on Mazindol’s Neuroprotective Effects in Narcoleptic-like Rat Model
    Via ACCESSWIRE
    NLS Pharmaceutics Announces Receipt of Additional Staff Delisting Determination from Nasdaq
    Via ACCESSWIRE

    Performance

    YTD
    -75.80%
    -75.80%
    1 Month
    +13.84%
    +13.84%
    3 Month
    -64.42%
    -64.42%
    6 Month
    -64.44%
    -64.44%
    1 Year
    -85.33%
    -85.33%

    More News

    Read More
    NLS Pharmaceutics Announces Receipt of Staff Delisting Determination from Nasdaq; Intends to Request Hearing
    Via ACCESSWIRE
    NLS Pharmaceutics Announces Closing of $1.75 Million Registered Direct Offering
    Via ACCESSWIRE
    NLS Pharmaceutics Announces $1.75 Million Registered Direct Offering
    Via ACCESSWIRE
    NLS Pharmaceutics Secures Exclusive Global License for Next-Generation Non-Sulfonamide Dual Orexin Agonist Platform
    Via ACCESSWIRE
    NLS Pharmaceutics to Participate in the BIO-EUROPE Springtime Partnering Event
    Via ACCESSWIRE
    Nasdaq Accepts NLS Pharmaceutics’ Plan to Regain Listing Compliance
    Via ACCESSWIRE
    NLS Pharmaceutics Submits Plan to Regain Listing Compliance With Nasdaq
    Via ACCESSWIRE
    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
    Via InvestorPlace
    Notice of Deficiency with Nasdaq Continued Listing Requirements
    Via ACCESSWIRE
    NLS Pharmaceutics CEO Issues Letter to Shareholders
    Via ACCESSWIRE
    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
    Via InvestorPlace
    Spotify Layoffs 2023: What to Know About the Latest SPOT Job Cuts
    Via InvestorPlace
    Topics Workforce
    Exposures Layoff
    Evercore ISI Is Souring on Fisker (FSR) Stock
    Via InvestorPlace
    Why U Power Shares Are Trading Lower By Around 54%? Here Are Other Stocks Moving In Monday's Mid-Day Session
    Via Benzinga
    Why Is Garden Stage (GSIW) Stock Down 38% Today?
    Via InvestorPlace
    Why Is NLS Pharmaceutics (NLSP) Stock Down 24% Today?
    Via InvestorPlace
    Why Hawaiian Airlines Shares Are Trading Higher By Over 180%; Here Are 20 Stocks Moving Premarket
    Via Benzinga
    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
    Via InvestorPlace
    NLS Pharmaceutics Announces Exclusive Option Agreement to Develop and Commercialize Next Generation Dual Orexin Agonist Platform of Aexon Labs, Inc.
    Via ACCESSWIRE
    NLS Pharmaceutics Announces Election of Additional Board Members
    Via ACCESSWIRE
    NLS Pharmaceutics to Participate in the Oppenheimer Sleep Disorders Summit: Deep Dive into Narcolepsy and Idiopathic Hypersomnia
    Via ACCESSWIRE
    Why Children's Place Shares Are Trading Lower By Around 25%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
    Via Benzinga
    Why NLS Pharmaceutics (NLSP) Stock Is Down 40% Today
    Via Benzinga
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.